Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Treating VX

Activists, stakeholders oppose Army plan to ship, treat, and dispose of VX wastewater

by Lois Ember
April 17, 2006 | A version of this story appeared in Volume 84, Issue 16

In an unusual alliance, environmental activists, union members, local elected officials, and others have banded together to urge the Army to reconsider its plan to truck wastewater created from the destruction of VX nerve agent in Indiana to New Jersey for final treatment.

The Army plans to transport the toxic wastewater, or hydrolysate, to a DuPont hazardous waste treatment facility in Deepwater, N.J., for processing and ultimate disposal in the Delaware River. The alliance is asking the Army to revert to its original plan to use supercritical water oxidation (SCWO) to treat the hydrolysate on-site at its Newport, Ind., disposal facility.

Jeff Lindblad, spokesman for the Army's Chemical Materials Agency, says using SCWO to treat VX "would add at least two years and an additional $300 million in cost" to the project. But Chemical Weapons Working Group spokeswoman Elizabeth Crowe counters, "The Army has released no detailed assessment showing how off-site treatment will be faster and cheaper" than using SCWO on-site.

Jim Rowe, president of United Steelworkers Local 943 in Deepwater, has concerns about maintenance of the treatment facility and the future harm to human health and the environment.

DuPont spokesman Anthony Farina says the company "would only be involved in the project if it can be accomplished safely and effectively" with no harm to the community or the environment.

To date, the Army has hydrolyzed about 198,300 gal of VX at Newport but has had to store the hydrolysate on-site until the Centers for Disease Control & Prevention releases its congressionally mandated risk assessment of the Army's plan. This report will be released later this month, probably after Congress returns from recess on April 24.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.